JP2003530872A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003530872A5 JP2003530872A5 JP2001578467A JP2001578467A JP2003530872A5 JP 2003530872 A5 JP2003530872 A5 JP 2003530872A5 JP 2001578467 A JP2001578467 A JP 2001578467A JP 2001578467 A JP2001578467 A JP 2001578467A JP 2003530872 A5 JP2003530872 A5 JP 2003530872A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- polynucleotide
- symbol
- seq
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 description 28
- 102000004196 processed proteins & peptides Human genes 0.000 description 28
- 108090000765 processed proteins & peptides Proteins 0.000 description 28
- 239000002157 polynucleotide Substances 0.000 description 20
- 102000040430 polynucleotide Human genes 0.000 description 20
- 108091033319 polynucleotide Proteins 0.000 description 20
- 239000000203 mixture Substances 0.000 description 12
- 229960005486 vaccine Drugs 0.000 description 11
- 239000012634 fragment Substances 0.000 description 10
- 239000002773 nucleotide Substances 0.000 description 10
- 125000003729 nucleotide group Chemical group 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 125000003275 alpha amino acid group Chemical group 0.000 description 6
- 230000002163 immunogen Effects 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20007400P | 2000-04-27 | 2000-04-27 | |
| US60/200,074 | 2000-04-27 | ||
| PCT/US2001/013828 WO2001081380A2 (en) | 2000-04-27 | 2001-04-27 | Immunogenic pneumococcal protein and vaccine compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003530872A JP2003530872A (ja) | 2003-10-21 |
| JP2003530872A5 true JP2003530872A5 (https=) | 2008-07-03 |
Family
ID=22740214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001578467A Pending JP2003530872A (ja) | 2000-04-27 | 2001-04-27 | 免疫原肺炎連鎖球菌タンパク質とそのワクチン組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6689369B2 (https=) |
| EP (1) | EP1278856A2 (https=) |
| JP (1) | JP2003530872A (https=) |
| AU (2) | AU5577201A (https=) |
| CA (1) | CA2407455A1 (https=) |
| WO (1) | WO2001081380A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| DE69942176D1 (de) * | 1998-04-07 | 2010-05-06 | Medimmune Llc | Choline-bindende proteine derivate aus pneumokoken als impfstoff |
| US6858706B2 (en) * | 1998-04-07 | 2005-02-22 | St. Jude Children's Research Hospital | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| WO2002083855A2 (en) | 2001-04-16 | 2002-10-24 | Wyeth Holdings Corporation | Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| PT2268618E (pt) | 2008-03-03 | 2015-10-12 | Novartis Ag | Compostos e composições moduladores da actividade tlr |
| CA2765112A1 (en) | 2009-06-10 | 2010-12-16 | Novartis Ag | Benzonaphthyridine-containing vaccines |
| JO3257B1 (ar) | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
| ES2443952T3 (es) | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
| CN102695523A (zh) | 2009-09-10 | 2012-09-26 | 诺华有限公司 | 针对呼吸道疾病的组合疫苗 |
| WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
| SG10201501980SA (en) | 2009-12-15 | 2015-05-28 | Novartis Ag | Homogeneous suspension of immunopotentiating compounds and uses thereof |
| AU2011232421B2 (en) | 2010-03-23 | 2015-08-13 | Novartis Ag | Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| WO2012072769A1 (en) | 2010-12-01 | 2012-06-07 | Novartis Ag | Pneumococcal rrgb epitopes and clade combinations |
| JP2015510872A (ja) | 2012-03-07 | 2015-04-13 | ノバルティス アーゲー | Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤 |
| JP6411378B2 (ja) | 2013-02-01 | 2018-10-24 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Ｔｏｌｌ様受容体アゴニストを含む免疫学的組成物の皮内送達 |
| ES2985591T3 (es) | 2018-02-12 | 2024-11-06 | Inimmune Corp | Ligandos de receptores tipo Toll |
| KR20230098825A (ko) | 2020-11-04 | 2023-07-04 | 엘리고 바이오사이언스 | 씨. 아크네스 개체군에게 dna 페이로드의 원위치 전달을 위한 파지-유래 입자 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0956289A4 (en) * | 1996-08-16 | 2004-10-13 | Smithkline Beecham Corp | NOVEL PROKARYOTA POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF |
| JP4469026B2 (ja) * | 1996-10-31 | 2010-05-26 | ヒューマン ジノーム サイエンシーズ，インコーポレイテッド | Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅの抗原およびワクチン |
-
2001
- 2001-04-27 US US09/844,124 patent/US6689369B2/en not_active Expired - Lifetime
- 2001-04-27 AU AU5577201A patent/AU5577201A/xx active Pending
- 2001-04-27 WO PCT/US2001/013828 patent/WO2001081380A2/en not_active Ceased
- 2001-04-27 EP EP01928972A patent/EP1278856A2/en not_active Ceased
- 2001-04-27 JP JP2001578467A patent/JP2003530872A/ja active Pending
- 2001-04-27 CA CA002407455A patent/CA2407455A1/en not_active Abandoned
- 2001-04-27 AU AU2001255772A patent/AU2001255772B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003530872A5 (https=) | ||
| AU2007271350B2 (en) | Small Streptococcus pyogenes antigens and their use | |
| JP2002542827A5 (https=) | ||
| CA2371714A1 (en) | Streptococcus pneumoniae proteins and vaccines | |
| RU2757426C2 (ru) | Иммунногенный слитый белок | |
| JP2008529558A5 (https=) | ||
| JP2002507396A5 (https=) | ||
| JP2003501110A5 (https=) | ||
| WO2001045639A3 (en) | Methods for protecting against lethal infection with bacillus anthracis | |
| CN103068838A (zh) | 基于重组蛋白的抗链球菌感染疫苗 | |
| JP5437813B2 (ja) | Ｓ．アガラクティエの防御タンパク質、その組み合わせ、およびそれを使用する方法 | |
| JP2002512800A5 (https=) | ||
| KR102675880B1 (ko) | SARS-CoV-2 스파이크 단백질 및 면역글로불린의 Fc 유래 단백질을 포함하는 재조합 단백질 및 이의 용도 | |
| CN118873646A (zh) | 一种抑制a组链球菌感染的重组蛋白疫苗及其应用 | |
| KR102675879B1 (ko) | SARS-CoV-2 스파이크 단백질 S1 유래 단백질 및 페리틴 유래 단백질을 포함하는 재조합 단백질 및 이의 용도 | |
| KR102675881B1 (ko) | Pedv 스파이크 단백질 s1 유래 단백질 및 페리틴 유래 단백질을 포함하는 재조합 단백질 및 이의 용도 | |
| Stanley | Progress towards an amebiasis vaccine | |
| JP2024512722A (ja) | 免疫原性融合タンパク質 | |
| CN107974458A (zh) | 表达猪丹毒杆菌重组蛋白GAPDH的基因gapdh及其重组大肠杆菌与应用 | |
| CN114437235A (zh) | 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用 | |
| US7041295B2 (en) | Compounds for treatment of infectious and immune system disorders and methods for their use | |
| JP2004502782A5 (https=) | ||
| WO2023044327A1 (en) | Recombinant vaccine compositions | |
| Adeyemi | A bacteriophage-based, highly efficacious, needle and adjuvant-free, mucosal COVID-19 vaccine | |
| KR20240175004A (ko) | Pedv 스파이크 단백질 s1 및 페리틴 유래 단백질을 포함하는 재조합 단백질 및 이의 용도 |